| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-22 05:56:34 UTC |
|---|
| Update Date | 2016-11-09 01:15:57 UTC |
|---|
| Accession Number | CHEM019243 |
|---|
| Identification |
|---|
| Common Name | Fosamprenavir calcium |
|---|
| Class | Small Molecule |
|---|
| Description | Fosamprenavir (marketed by ViiV Healthcare as the calcium salt under the trade names Lexiva in the U.S. and Telzir in Europe) is a drug for the treatment of HIV infections. It is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20, 2003, while the EMA approved it on July 12, 2004. The human body metabolizes fosamprenavir in order to form amprenavir, which is the active ingredient. That metabolization increases the duration that amprenavir is available, making fosamprenavir a slow-release version of amprenavir and thus reducing the number of pills required versus standard amprenavir.
A head-to-head study with lopinavir showed the two drugs to have comparable potency, but patients on fosamprenavir tended to have a higher serum cholesterol. Fosamprenavir's main advantage over lopinavir is that it is cheaper. |
|---|
| Contaminant Sources | - ToxCast & Tox21 Chemicals
|
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Lexiva | Kegg | | Telzir | Kegg | | (3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester | MeSH | | VX175 CPD | MeSH | | Fos-amprenavir | MeSH | | Fosamprenavir | MeSH | | GW908 CPD | MeSH | | Calcium;[(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphoric acid | Generator | | Calcium;[(2R,3S)-1-[(4-aminophenyl)sulphonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate | Generator | | Calcium;[(2R,3S)-1-[(4-aminophenyl)sulphonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphoric acid | Generator | | Fosamprenavir calcium | MeSH | | Calcium N-[(2S,3R)-3-(hydrogen phosphonatooxy)-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]-1-[(3S)-oxolan-3-yloxy]methanecarboximidic acid | Generator | | Calcium N-[(2S,3R)-3-(hydrogen phosphonatooxy)-4-[N-(2-methylpropyl)4-aminobenzenesulphonamido]-1-phenylbutan-2-yl]-1-[(3S)-oxolan-3-yloxy]methanecarboximidate | Generator | | Calcium N-[(2S,3R)-3-(hydrogen phosphonatooxy)-4-[N-(2-methylpropyl)4-aminobenzenesulphonamido]-1-phenylbutan-2-yl]-1-[(3S)-oxolan-3-yloxy]methanecarboximidic acid | Generator |
|
|---|
| Chemical Formula | C25H34CaN3O9PS |
|---|
| Average Molecular Mass | 623.670 g/mol |
|---|
| Monoisotopic Mass | 623.138 g/mol |
|---|
| CAS Registry Number | 226700-81-8 |
|---|
| IUPAC Name | calcium N-[(2S,3R)-3-(hydrogen phosphonatooxy)-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]-1-[(3S)-oxolan-3-yloxy]methanecarboximidate |
|---|
| Traditional Name | calcium N-[(2S,3R)-3-(hydrogen phosphonatooxy)-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]-1-[(3S)-oxolan-3-yloxy]methanecarboximidate |
|---|
| SMILES | [Ca++].[H][C@](CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1)(OP(O)([O-])=O)[C@]([H])(CC1=CC=CC=C1)N=C([O-])O[C@@]1([H])CCOC1 |
|---|
| InChI Identifier | InChI=1S/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/p-2/t21-,23-,24+;/m0./s1 |
|---|
| InChI Key | PMDQGYMGQKTCSX-HQROKSDRSA-L |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Aminobenzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminobenzenesulfonamide
- Phenylbutylamine
- Amphetamine or derivatives
- Benzenesulfonyl group
- Phosphoethanolamine
- Aniline or substituted anilines
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Organosulfonic acid amide
- Alkyl phosphate
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Aminosulfonyl compound
- Carbamic acid ester
- Tetrahydrofuran
- Sulfonyl
- Carbonic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Dialkyl ether
- Ether
- Organic calcium salt
- Organic nitrogen compound
- Organopnictogen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Primary amine
- Organic zwitterion
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00di-0000009000-95a294b3c9beee05048d | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00di-0000009000-95a294b3c9beee05048d | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00di-0000009000-95a294b3c9beee05048d | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-0000009000-f67ad6df1b5fddfff332 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00di-0000009000-f67ad6df1b5fddfff332 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00di-0000009000-f67ad6df1b5fddfff332 | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | DBSALT001228 |
|---|
| HMDB ID | Not Available |
|---|
| FooDB ID | Not Available |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Fosamprenavir |
|---|
| Chemspider ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| PubChem Compound ID | 131535 |
|---|
| Kegg Compound ID | Not Available |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | Not Available |
|---|